Dr. Mohammad Ebrahim Oreizi Esfahani, MD

Dr. Oreizi Esfahani practices at University of Maryland Surgical Center in Baltimore, Maryland.

Dr. Oreizi Esfahani's NPI, 1821085317, was assigned on September 30, 2005. Dr. Oreizi Esfahani graduated from St Joseph's University Medical School in 1989. Dr. Oreizi Esfahani's Maryland license number on file is D44533.

Dr. Oreizi Esfahani's primary practice is University of Maryland Surgical Center, at 419 W Redwood St, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-4080.

Dr. Oreizi Esfahani's primary practice is University of Maryland Surgical Center in Baltimore, Maryland. Dr. Oreizi Esfahani is also affiliated with University of Maryland Medical Center. The medical group on file is UM Community Medical Group. Dmand AI also links Dr. Oreizi Esfahani to 2 more medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oreizi Esfahani practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Oreizi Esfahani's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Oreizi Esfahani is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Oreizi Esfahani's licenses on file in 3 states: Maryland, Virginia and California.

Dmand AI lists arteritis, arthritis, fluid in a joint, gout, joint arthropathy, lupus, lyme disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Oreizi Esfahani treats.

CMS data shows 19,810 Medicare services from Dr. Oreizi Esfahani across 16 procedure codes in 2024, for 580 Medicare patients. Medicare paid $541,019 for them. Every service was in an office.

CMS counts 580 Medicare patients who saw Dr. Oreizi Esfahani in 2024. The largest group is 65 to 74, with 253 patients. 75% of them have arthritis, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Oreizi Esfahani's median patient age at 54, with 73% women.

In 2024, Dr. Oreizi Esfahani wrote 1,609 Medicare Part D claims for 363 patients. 90% of them were for generic drugs. CMS names the drug for 1,437 of them, across 25 drugs with 11 or more claims each, at $878,072 in total drug cost. In 2023, CMS named 1,470 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Oreizi Esfahani for performance year 2024, reported as part of a group. Dr. Oreizi Esfahani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 380 general payments to Dr. Oreizi Esfahani from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $1,330.

Dr. Oreizi Esfahani graduated from St Joseph's University Medical School in 1989.

Dr. Oreizi Esfahani is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.